ABP vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

ABP

50.6
AI Score
VS
XRAY Wins

XRAY

52.3
AI Score

Investment Advisor Scores

ABP

51score
Recommendation
HOLD

XRAY

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABP XRAY Winner
Forward P/E 0 10.0705 Tie
PEG Ratio 0 0.7521 Tie
Revenue Growth -100.0% 0.1% XRAY
Earnings Growth 0.0% 15.2% XRAY
Tradestie Score 50.6/100 52.3/100 XRAY
Profit Margin 0.0% -17.1% ABP
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABP 1M: -84.0% · 3M: -91.1% XRAY 1M: +20.6% · 3M: +13.8%

Current Technical Phase

ABP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.3%), weak momentum, RSI 22

RSI (14): 22.2 · Price: $0.52

XRAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 58

RSI (14): 57.8 · Price: $13.37

Fundamentals Snapshot

Metric ABP XRAY
Market Cap
Forward P/E -0.1 8.6
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin 0.5%
Operating Margin 0.0% 0.0%
EPS -8.25 -3.05
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.